I now have comprehensive content from multiple authoritative sources. Let me synthesize a thorough response.
Angina Pectoris
Definition
Angina pectoris is intermittent chest discomfort or pain caused by transient, reversible myocardial ischemia that is insufficient to cause myocyte necrosis. It results from the ischemia-induced release of adenosine, bradykinin, and other molecules that stimulate autonomic afferent nerves. — Robbins & Kumar Basic Pathology
Epidemiology
Nearly 10 million Americans have angina pectoris. Males constitute ~70% of all patients, and an even greater proportion of those aged <50 years. Among adults aged 60–79, ~25% of men and 16% of women have coronary heart disease. Angina is the most frequent clinical expression of myocardial ischemia. — Harrison's Principles of Internal Medicine 22E; Goldman-Cecil Medicine
Pathophysiology
Ischemia rapidly develops when a mismatch arises between myocardial oxygen demand and myocardial oxygen supply. The most common underlying cause is obstructive coronary atherosclerosis. Alternative mechanisms include:
- Microvascular dysfunction (angina with no obstructive CAD)
- Vasoconstriction at the site of a dynamic stenosis
- Mural thrombosis
- Noncardiac conditions that increase demand or reduce supply (severe anemia, aortic stenosis, hypertrophic cardiomyopathy)
— Goldman-Cecil Medicine
Types
1. Stable (Typical) Angina
Predictable, episodic chest discomfort associated with exertion or increased demand (tachycardia). The discomfort is described as a crushing or squeezing substernal sensation, radiating down the left arm or to the jaw. Relieved by rest or nitroglycerin within minutes. — Robbins
2. Prinzmetal (Variant) Angina
Occurs at rest, caused by coronary artery spasm. Can affect atherosclerotic or even otherwise healthy vessels. Responds promptly to vasodilators (nitroglycerin, calcium channel blockers). — Robbins
3. Unstable Angina
Increasingly frequent pain precipitated by progressively less exertion or occurring at rest. Associated with plaque disruption, superimposed thrombosis, distal embolization, and/or vasospasm. Majority of cases show evidence of myocyte injury — treated aggressively to limit irreversible damage. — Robbins
Clinical Presentation (History)
The typical patient is a man >50 years or a woman >60 years. Key features:
- Quality: Heaviness, pressure, squeezing, smothering, or choking — rarely described as frank "pain"
- Location: Central, substernal; patient often places a clenched fist over the sternum (Levine's sign)
- Radiation: Shoulders, both arms (especially ulnar aspects), back, interscapular region, neck, jaw, teeth, epigastrium
- Duration: Typically 2–5 minutes, crescendo-decrescendo pattern
- Precipitants: Exertion, emotional stress, cold exposure, heavy meals, sexual activity
- Relief: Rest, nitroglycerin
- Angina decubitus: Can occur at rest or when recumbent — may reflect nocturnal tachycardia or increased intrathoracic blood volume during sleep
Myocardial ischemic discomfort does NOT radiate to the trapezius muscles — that pattern is more typical of pericarditis. Angina is rarely localized below the umbilicus or above the mandible.
— Harrison's Principles of Internal Medicine 22E
Grading — Canadian Cardiovascular Society (CCS) Scale
| Class | Description |
|---|
| I | Angina only with strenuous or prolonged exertion |
| II | Slight limitation of ordinary activity |
| III | Marked limitation of ordinary activity |
| IV | Inability to perform any activity without angina, or angina at rest |
Classes I–II = stable; Classes III–IV = severe/unstable. — Goldman-Cecil Medicine
Investigations
- Resting ECG: May show ST-segment depression, T-wave changes, or evidence of prior MI
- Stress testing (exercise ECG, nuclear imaging, stress echo): To provoke and detect ischemia
- Coronary CT angiography / coronary artery calcium (CAC) score: Adjunctive evidence of atherosclerosis
- Lab work: CBC, fasting lipid profile, fasting glucose/HbA1c, thyroid function, renal function
- Coronary angiography: Gold standard for defining anatomy; guides revascularization decisions
- Echocardiography: Assesses LV function and wall motion
Management
General Approach
- Explain the condition and reassure the patient
- Identify and treat aggravating conditions (anemia, hypertension, hyperthyroidism, obesity, aortic stenosis)
- Adapt activity — reduce speed/intensity, understand diurnal variation in ischemic threshold
- Address cardiovascular risk factors (smoking, dyslipidemia, diabetes, hypertension)
- Drug therapy
- Consider revascularization (PCI or CABG)
Pharmacotherapy
| Drug Class | Examples | Mechanism | Role |
|---|
| Nitrates | Nitroglycerin, isosorbide dinitrate/mononitrate | Release NO → ↑cGMP → vasodilation; ↓venous return, ↓cardiac work | SL NTG for acute episodes; oral/transdermal for prophylaxis |
| Beta-blockers | Propranolol, metoprolol, atenolol | Block β-adrenoceptors → ↓HR, ↓CO, ↓BP → ↓O₂ demand | First-line prophylaxis |
| Calcium channel blockers | Verapamil, diltiazem (non-DHP); nifedipine, amlodipine (DHP) | Block L-type Ca²⁺ channels → ↓vascular resistance and/or ↓cardiac work | Variant angina (especially); stable angina when beta-blockers are contraindicated |
| Antiplatelet | Aspirin, clopidogrel | Inhibit platelet aggregation | Reduce thrombotic events |
| Statins | Atorvastatin, rosuvastatin | ↓LDL cholesterol, plaque stabilization | Reduce CV events, mandatory in IHD |
| Ranolazine | Ranolazine | Inhibits late sodium current → ↓intracellular Ca²⁺ overload | Refractory angina, adjunctive therapy |
Key interaction: Nitrates + phosphodiesterase type-5 inhibitors (sildenafil, tadalafil) → synergistic severe hypotension — combination is contraindicated. — Katzung's Basic and Clinical Pharmacology 16E
Revascularization
- Percutaneous coronary intervention (PCI): For focal lesions, especially in single- or two-vessel disease
- Coronary artery bypass grafting (CABG): Preferred in left main disease, three-vessel disease, or with LV dysfunction
Prognosis
Prognosis is influenced by:
- Severity of LV dysfunction (ejection fraction)
- Number of coronary vessels with significant obstruction
- Extent of viable but jeopardized myocardium
- Presence of risk factors (age >75, hypertension, diabetes, dyslipidemia, obesity, peripheral vascular disease, prior MI)
- Elevated CRP, extensive coronary calcification on CT, carotid intimal thickening — all indicate higher risk
— Harrison's Principles of Internal Medicine 22E
Sources: Robbins & Kumar Basic Pathology | Harrison's Principles of Internal Medicine 22E | Goldman-Cecil Medicine | Katzung's Basic and Clinical Pharmacology 16E